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Edited by Veli-Pekka LehtoAbstract Coeliac disease is a chronic enteropathy caused by the
ingestion of wheat gliadin and other cereal prolamines derived
from rye and barley. In the present work, we investigated the
mechanisms underlying altered barrier function properties ex-
erted by gliadin-derived peptides in human Caco-2 intestinal epi-
thelial cells. We demonstrate that gliadin alters barrier function
almost immediately by decreasing transepithelial resistance and
increasing permeability to small molecules (4 kDa). Gliadin
caused a reorganisation of actin ﬁlaments and altered expression
of the tight junction proteins occludin, claudin-3 and claudin-4,
the TJ-associated protein ZO-1 and the adherens junction pro-
tein E-cadherin.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Coeliac disease is an autoimmune enteropathy triggered by
ingestion of gluten containing grains in susceptible individuals
with HLA-DQ2/8 haplotypes. It is one of the commonest dis-
orders in most populations (P 1:200) and is marked by a life-
long intolerance to dietary gluten that leads to severe damage
to the small-intestinal mucosa [1,2]. Exposure of intestinal epi-
thelial cells to gliadin, the ethanol-soluble fraction of gluten,
can cause a range of eﬀects including growth inhibition, mod-
iﬁcation of cellular morphology, apoptosis, cytoskeletal altera-
tions, inhibition of DNA and RNA synthesis and altered
oxidative balance [3].
Gliadin peptides cross the intestinal epithelial barrier and
reach the lamina propria of the intestinal mucosa where they
are recognized by antigen presenting cells. Despite progress
made in understanding the subsequent immunological events
in the pathogenesis of coeliac disease, the nature of the under-
lying permeability defects and the mechanism that allows glia-*Corresponding author. Fax: +61 08 8239 0267.
E-mail address: guy.sander@adelaide.edu.au (G.R. Sander).
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doi:10.1016/j.febslet.2005.07.066din to cross the intestinal epithelium are largely unknown.
Normal intestinal epithelium is impermeable to macromole-
cules, however coeliac disease is characterized by enhanced
intestinal permeability [4] and an altered junctional structure
between epithelial cells, leading to compromised barrier func-
tion [5].
Mucosal barrier function is regulated by the epithelial apical
junctional complex consisting of the tight junction (TJ) and the
adherens junction (AJ). TJs are a specialized intercellular pro-
tein complex involving interaction of transmembrane-bound
proteins on adjacent cells. TJs mediate vectorial transport of
water and electrolytes across the intestinal epithelium and pre-
vent leakage of macromolecules from the gut lumen (reviewed
in [6,7]). TJ components include a unique protein, occludin,
and two families of proteins, the junctional adhesion molecules
(JAM) of which there are four proteins, and the claudins, a
family of at least 24 proteins that exhibit tissue-speciﬁc distri-
butions [8]. In the intestinal epithelium, various combinations
of claudins, JAMs and occludin are assembled into the TJ in
speciﬁc crypt-villus patterns [9,10]. Only claudins 1–5 have
been characterized in any detail in normal gut and there is a
lack of information on whether members of the TJ family
are altered in coeliacs.
Functional, structural and molecular analyses show that the
intercellular junctions between intestinal epithelial cells are
abnormal in coeliac patients [5,11–13]. Coeliac individuals
have fewer TJ protein strands [5] and less of the TJ-associated
protein ZO-1 [13,14], pointing to structural alterations at the
TJ. In these studies, ZO-1 appeared to return to normal on a
gluten-free diet but the TJ strand number did not, which could
indicate a more persistent structural defect at the TJ itself. Pro-
teins at the AJ have also been shown to be altered in coeliac
disease. The AJ protein E-cadherin, required for TJ formation
is reduced in the duodenal epithelium of children with coeliac
disease [15].
Caco-2 cells are regarded as a good model of human intesti-
nal enterocytes and have previously been used to study eﬀects
of gliadin on metabolism, oxidative balance and apoptosis
[3,16]. We have used Caco-2 cells to study the eﬀects of gliadin
on junctional proteins, focussing on those that are well known
to be expressed in these cells. We have found that gliadin rap-
idly increases permeability of Caco-2 monolayers and show
that it alters the actin cytoskeleton and junctional proteins in-
volved in barrier function.blished by Elsevier B.V. All rights reserved.
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2.1. Gliadin peptic–tryptic digest
The gliadin fraction was extracted from whole cereal ﬂour of bread
wheat as previously described by Auricchio et al. [17]. The gliadin frac-
tion was subjected to sequential digestion according to de Ritis et al.
[18]. Peptic–tryptic digests were lyophilized and stored at 20 C. Gli-
adin fractions were added to the lumen side of Caco-2 cell monolayers
on permeable supports at 1 mg/ml.
2.2. Cell culture
Caco-2 cells (ATCC; passage 52–55) were grown for 28 days in a 5%
CO2 humidiﬁed incubator at 37 C on T75 tissue culture ﬂasks (Corn-
ing Costar, Acton, MA) with media containing Dulbeccos modiﬁed
Eagles medium (GIBCO) supplemented with 20% heat inactivated
FCS and antibiotics (100 U/ml aqueous penicillin G, 100 g/ml strepto-
mycin, at a pH of 7.4. Cells were passaged weekly (1:3) upon reaching
80% conﬂuence.
2.3. Barrier function measurements
Caco-2 cells were plated onto Transwell clear polyester permeable
membranes (Corning Costar) and media changed every 3 days. Cells
were maintained until steady-state transepithelial electrical resistance
(TER) was achieved and used 21 days later. The resistance across con-
ﬂuent monolayers was measured using a millicell-ERS volt-ohm meter
(Millipore) with ‘‘chopstick’’ electrodes. Values were expressed as
ohms per square centimeter, taking into account the surface area of
the ﬁlter (4.7 cm2). Baseline levels of TER in conﬂuent Caco-2 mono-
layers exceeded 500 X/cm2. Conﬂuent Caco-2 monolayers were equili-
brated overnight in 1· PBS supplemented with 1.26 mM, CaCl2, 1 mM
MgCl2, 0.02% glucose, 10 mM HEPES, Non-essential Amino Acids
(Gibco), Na Pyruvate, Pen/Strep, 2 mM glutamine, 2 lg/ml human
apo-Transferrin at pH 7.4, 10% FCS. Cells were then equilibrated
the following day in the above media containing 1% FCS for 2 h before
the addition of gliadin. Eﬀects on permeability were evaluated by mea-
suring ﬂux of 4 and 70 kDa FITC dextran (Sigma) using a Wallac Vic-
tor2 1420 Multilabel ﬂuorescent plate reader (Perkin Elmer).2.4. Extraction of cell protein lysates
Monolayers were grown on polyester membranes (4.7 cm2) for Wes-
tern blot experiments, as previously described (Youakim et al., 1999).
NP40-soluble and -insoluble fractions were used to help deﬁne the
location of TJ proteins (Sakikabira, 1997; Youakim, et al, 1999).
Caco-2 monolayers grown on 4.7-cm2 Transwell inserts were washed
twice in ice-cold PBS and then lysed using a 1% NP-40 based lysis buf-
fer (1% NP-40, 50 mM Tris–HCl, pH 7.5, 140 mM EGTA, 30 mM so-
dium pyrophosphate, 50 mM NaF, 100 mM Na3VO4 and Complete
protease inhibitor cocktail tablets (Boehringer Mannheim, Indianapo-
lis) and scraped from the ﬁlter using a rubber policeman. The lysate
was spun at 30000 · g and the supernatant removed and designated
the NP40 soluble fraction. The remaining cellular residue was solubi-
lized using 1% SDS-based lysis buﬀer (1% SDS, 50 mM Tris–HCl,
pH 7.5, 140 mM EGTA, 30 mM sodium pyrophosphate, 50 mM
NaF, 100 M Na3VO4, and Complete protease inhibitor cocktail tab-
lets). The cellular residue was passed 10 times through successive syrin-
ges (25, 20 and 17 g). The lysate was spun at 30000 ·g and the
supernatant was designated the NP40-insoluble fraction. Protein con-
centrations were measured by the Bradford method, and 10 lg of
NP40-soluble and 5 lg insoluble fractions were loaded into separate
lanes for detection of claudin-1, whereas 2.5 lg of each fraction was
loaded for detection of claudin-3 and claudin-4.
2.5. Gel electrophoresis and Western blotting
Samples were loaded following addition of LDS buﬀer (Invitrogen)
and boiling for 5 min. Proteins were separated by electrophoresis on 3–
8% or 12% Nupage gels (Invitrogen) and transblotted on nitrocellulose
membranes, followed by a one-hour incubation at room temperature
in blocking buﬀer (containing 20 mM Tris (pH 7.5), 500 mM NaCl,
5% non-fat dry milk, 0.2% Tween-20) then a one-hour incubation with
blocking buﬀer containing primary antibody. Primary antibodies ZO-
1, occludin, E-cadherin and claudins-1, -3 and -4 were purchased from
Zymed (San Francisco, CA). Incubation with primary antibody was
followed by a 30 min rinse in wash buﬀer (20 mM Tris, pH 7.5,500 mM NaCl, 0.2% Tween-20), a one-hour incubation with blocking
buﬀer containing secondary antibody, and another 30 min rinse in
wash buﬀer. Bands were detected using West pico Supersignal-ECL
detection reagents (Amersham Piscataway, NJ). Gel electrophoresis
and gel blotting reagents were purchased from BioRad (Hercules, CA).
2.6. Immunoﬂuorescence labelling
Caco-2 monolayers exposed to gliadin for four hours were washed
three times with phosphate-buﬀered saline (PBS) and ﬁxed/permeabili-
zed in 100% ethanol at 20 C for 20 min. Non-speciﬁc background was
blocked with 5% powdered milk (Carnation brand) in PBS and 0.1%
Tween (1 h at room temperature). Monolayers were incubated over-
night with primary antibodies to occludin (1/400), ZO-1 (1/400), clau-
din-1 (1/100), claudin-3 (1/100), claudin-4 (1/100) and E-cadherin (1/
200). Monolayers were washed and probed with Alexa-Fluor-488/555
(1/100; Molecular Probes) or Cy-3-conjugated (1/200; Jackson Immu-
noResearch Laboratories, West Grove, PA) secondary antibodies. To
detect F-Actin, cells were stained with 0.3 lM ﬂuorescein phalloidin
(Sigma) in PBS at 37 C for 30 min. Nuclei were counterstained with
propidium iodide (Molecular Probes) and mounted with DAPI (Dak-
oCytomation). All monolayers were visualized on an LSM510 confo-
cal microscope (Carl Zeiss Microimaging, Thornwood, NY).2.7. Statistical analysis
Data are presented as arithmetic means of at least three independent
experiments ± S.D. Statistical analysis was performed by Students t-
test. P values smaller than 0.01 were considered to be signiﬁcant.3. Results
3.1. Eﬀect of gliadin on Caco-2 monolayer permeability
To assess the eﬀects of gliadin on Caco-2 permeability, we
measured both TER and FITC dextran ﬂux (Fig. 1). Addition
of gliadin (1 mg/ml) to the lumen side of Caco-2 cell monolay-
ers grown on permeable supports led to an immediate reduc-
tion in TER. The TER of gliadin-treated Caco-2 cells
decreased to 40% of control TER by 100 min and remained
at this level during the course of the experiment. The eﬀect
of gliadin on permeability was reversible as TER recovered
to baseline values after overnight incubation in media without
gliadin (data not shown). The involvement of the paracellular
pathway was conﬁrmed by increased ﬂux of the 4 kDa FITC
Dextran paracellular marker. By the time maximal, TER de-
crease was observed at 100 min, ﬂux had increased 3-fold,
and by 4 h ﬂux had increased 6-fold, from 0.05 lg/cm2 (con-
trol) to 0.3 lg/cm2 (treatment) after four hours gliadin treat-
ment. There was no change in the ﬂux of 70 kDa FITC
Dextran molecules over this time period suggesting that the
integrity of the monolayer was intact and that the disrupted
barrier was size selective.
3.2. Gliadin reduces the levels of TJ proteins, ZO-1 and E-
cadherin in Caco-2 cells
The eﬀect of gliadin on proteins that are known to be themain
components of the TJ and AJ in Caco-2 cells, namely claudins-
1, -3, -4, occludin, ZO-1 and E-cadherin was analysed by Wes-
tern blot (Fig. 2). Claudins-1, -3 and -4 each showed diﬀerences
in their relative abundance in NP40 soluble and insoluble frac-
tions. Claudin-1 was detected solely in the soluble fraction,
whereas claudin-3 was detected only in the insoluble fraction.
Claudin-4 was detected in both fractions but was most abun-
dant in the soluble fraction. We saw a modest reduction in the
expression levels of these proteins after 4 h of gliadin treatment.
No change in claudin-1 expression was detected. Occludin and
Fig. 1. Eﬀect of gliadin on transepithelial electrical resistance (TER)
and FITC dextran ﬂux in Caco-2 cells grown on polyester Transwells.
(A) Addition of gliadin (h) led to a reduction in TER within 10 min
(n = 12). No change in TER was observed with the addition of BSA
(h). (B) Addition of gliadin to Caco-2 monolayers led to an increase in
the ﬂux of 4 kDa FITC dextran (n = 6). No increase in 4 kDa FITC
dextran ﬂux was observed when BSA was added to Caco-2 cells. (C)
Gliadin did not increase the ﬂux of 70 kDa FITC dextran (n = 5). Data
obtained from at least three independent experiments are expressed as
means ± S.D.; diﬀerences between values at individual time intervals
were calculated by Students t test. *P < 0.01.
Fig. 2. Expression of TJ, TJ-associated and AJ proteins in Caco-2 cells
after 4-h incubation with gliadin. Protein fractions were immunoblot-
ted with antibodies to claudins-1, -3, -4, occludin, ZO-1 and E-
cadherin expression. Images are representative of two independent
experiments. C = BSA (no gliadin), T = gliadin addition, S = NP40
soluble and I = NP40 insoluble.
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fraction and gliadin treatment caused a marked decrease in
expression of both phosphorylated and non-phosphorylated
forms. The TJ-associated protein ZO-1 was exclusively associ-
ated with the NP40 insoluble fraction and treatment with glia-
din resulted in a substantial decrease in expression. Western
blot analysis revealed that E-cadherin was equally distributed
in NP40 soluble and insoluble fractions and its expression de-
creased in both fractions after gliadin treatment (Fig. 2).
3.3. Fluorescence microscopic analysis of F-Actin, TJ and TJA
proteins
Immunoﬂuorescence localization of the TJ proteins demon-
strated an intact junctional network before and after gliadintreatment (Fig. 3). In control, untreated monolayers, clau-
dins-1, -3, -4 and occludin were predominantly localized to
the apical lateral membrane, producing a characteristic ‘‘hon-
eycomb’’ pattern consistent with their distribution in TJs
(Fig. 3A–H). Addition of gliadin to the apical side of Caco-2
cells had no noticeable inﬂuence on the expression of clau-
din-1 but did have a marked eﬀect on claudins-3, -4 and occlu-
din. Gliadin treatment caused a decrease in plasma membrane
staining and an increase in punctate, cytosolic staining of clau-
dins-3, -4 and occludin.
One of the most noticeable changes in expression was with
F-Actin (Fig. 3I and J). Gliadin caused a reorganisation and
an increase in polymerisation of intracellular actin ﬁlaments
characterized by redistribution to the cell subcortical compart-
ment as stress ﬁbres. E-cadherin was localized at the AJ in
both gliadin treated and untreated cells and a reduction in
its expression (Fig. 3K and L) was not overtly noticeable by
confocal microscopy as compared to ZO-1 (Fig. 3MN). In un-
treated Caco-2 cells, the TJA protein ZO-1 was expressed at
the TJ in a honeycomb pattern as well as faintly in the nucleus.
Addition of gliadin caused a reduction in expression of ZO-1
at the TJ and expression in the nucleus was not detectable.4. Discussion
Intestinal barrier function depends in part on the integrity of
the intestinal epithelium, a monolayer of cells connected to one
another by TJs located near the apical surface. TJ proteins
govern the passive passage of ions, solutes, peptides and pro-
teins from the lumen to the mucosa via the paracellular route.
Ions, solutes and proteins can also be absorbed by transcellu-
lar transportation through the cell and once absorbed, proteins
are degraded into smaller peptides by lysosomes and rendered
non-immunogenic. Defects in TJ and TJA proteins due to
stress, pathogens or inﬂammatory cytokines increase intestinal
epithelial permeability and allow unwanted molecules to pass
through the paracellular route. These proteins which are
thought to be immunogenic and may result in antigen-speciﬁc
immune responses as seen in coeliac disease.
When gliadin is ingested by coeliacs it is initially associated
with the apical surface and intercellular space between cells
Fig. 3. Confocal analysis of claudins-1, -3, -4, -5, occludin, ZO-1 and E-cadherin expression in Caco-2 cells after 4-h incubation with gliadin or
control (BSA). Cell nuclei were stained with propidium iodide (panels K and L). Images are representative of three independent experiments. Panels
A, C, E, I, K, M = control monolayers, B, D, F, H, J, L, N = gliadin-treated monolayers. A, B = Claudin-1; C, D = Claudin-3; E, F = Claudin-4; G,
H = occludin; I, J = F-Actin; K, L = E-Cadherin; M, N = ZO-1. Bar = 20 lM.
4854 G.R. Sander et al. / FEBS Letters 579 (2005) 4851–4855and is then detectable in the cells, in contrast to normal sub-
jects where minimal uptake is observed [12]. Both paracellular
and transcellular transport mechanisms may operate in coeliac
patients and it has been proposed that transcellular uptake
may occur via the lateral membrane [12]. Hence, gliadin must
ﬁrst traverse the TJ barrier before it is absorbed.
Recent work is beginning to show that intestinal epithelial
barrier function can be aﬀected by gliadin which induces the
release of zonulin, the human homologue of zonnula occludens
toxin, elaborated by Vibrio cholerae [19,20]. Zonulin has been
shown to reversibly modulate TJ permeability and is upregu-
lated during the acute phase of coeliac disease [20]. It is also
released apically from rat intestinal epithelial cells exposed
on the lumen side to gliadin which causes permeability changes
in a protein kinase C dependent manner [19].
In the current study, we report that gliadin alters barrier
function in Caco-2 cell monolayers, a useful model of human
intestinal epithelia. Permeability, as measured by TER, in-
creased almost immediately after gliadin addition and reached
a maximum after 100 min that was sustained for the next
140 min. Immunogenic gliadin peptides are smaller than
4 kDa and we detected an increase in 4 kDa but not 70 kDa
FITC dextran ﬂux indicating that the increase in permeability
was selective to size. Changes in TJ expression were varied and
occurred within the ﬁrst 4 h of gliadin treatment. Claudins-3
and -4 were not signiﬁcantly reduced by treatment with gliadin
however, their location was altered, with an increase in ﬁne
punctate particles in the cytoplasm. This pattern of staining
is reminiscent of vesicular transport reported in other cells
and suggests that these proteins might be transported from
the TJ to cytoplasmic vesicles during this period. Occludin,
its phosphorylated form and ZO-1 were downregulated aftergliadin treatment. A reduction in ZO-1 in the nucleus of
Caco-2 cells after treatment with gliadin correlates with the
previous observation that ZO-1 in the nucleus of untreated
coeliac mucosa is signiﬁcantly lower than in the nucleus of nor-
mal or treated coeliac mucosa [13]. That ZO-1 did not increase
in the soluble fraction after treatment with gliadin suggests
that it was degraded and not chased from the insoluble frac-
tion. E-cadherin expression was also downregulated, a ﬁnding
that correlates with a previous study that reported a downreg-
ulation in coeliac disease [15,21]. That claudins-3, -4 and ZO-1
were isolated in the NP40 insoluble fraction suggests that the
actin cytoskeleton is intimately connected with these proteins.
Claudins are known to interact directly with TJ-speciﬁc, mem-
brane-associated guanylate kinase homologues, ZO-1, ZO-2,
and ZO-3, and indirectly with AF-6 and the myosin-binding
molecule, cingulin. These protein–protein interactions pro-
mote scaﬀolding of the TJ transmembrane proteins and pro-
vide a link to the actin cytoskeleton for transducing
regulatory signals to and from TJ [10]. Indeed, concomitant
with altered expression of claudins-3, -4 and ZO-1 was a reor-
ganization of actin ﬁlaments. Changes in intestinal enterocyte
F-actin after exposure of gliadin have been previously reported
in intestine-407 and IEC-6 cells [19,22]. In these studies, actin
ﬁlaments were reorganized by gliadin within 15 min in the rat
intestinal epithelial cell line IEC-6 [19]. Our results of an in-
crease in the polymerization of F-actin and alterations in
ZO-1 and E-cadherin expression in Caco-2 cells accord with
other studies of these molecules in intestinal epithelial cells
and support the use of Caco-2 cells as a model epithelium to
study coeliac disease.
In the present work, we show that in Caco-2 cells occludin,
claudins-3 and -4, F-actin, E-cadherin and ZO-1 are regulated
G.R. Sander et al. / FEBS Letters 579 (2005) 4851–4855 4855in a short period of time by gliadin. The alteration of these
proteins may provide a mechanistic link between the observa-
tion that gliadin causes an increase in intestinal epithelial per-
meability.
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